Expression and function of the ACE2/angiotensin(1-7)/Mas axis in osteosarcoma cell lines U-2 OS and MNNG-HOS

Molecular Medicine Reports

Volumn 10, Issue 2, 2014, Pages 804-810

  Ender, Stephan Albrecht ^a   Dallmer, Andrea ^a   Lässig, Florian ^a   Lendeckel, Uwe ^a   Wolke, Carmen ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Angiotensin(1 7); Mas; MNNG HOS; Osteosarcoma; Renin angiotensin system; U 2 OS

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7]; INTERLEUKIN 1BETA; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; MICROSOMAL AMINOPEPTIDASE; PROLYL ENDOPEPTIDASE; PROTEIN MAS; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANGIOTENSIN I; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; G PROTEIN COUPLED RECEPTOR; ONCOPROTEIN; PROTO-ONCOGENE PROTEINS C-MAS-1;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; OSTEOSARCOMA CELL LINE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANTAGONISTS AND INHIBITORS; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

ANGIOTENSIN I; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION; HUMANS; INTERLEUKIN-1BETA; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RECEPTORS, ANGIOTENSIN; RECEPTORS, G-PROTEIN-COUPLED; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84903304687     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2266     Document Type: Article

References (31)

1. Peach MJ: Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57: 313-370, 1977.
2. Deshayes F and Nahmias C: Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 16: 293-299, 2005. (Pubitemid 41206635)
3. Tamarat R, Silvestre JS, Durie M and Levy BI: Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 82: 747-756, 2002. (Pubitemid 34633824)
4. Pupilli C, Lasagni L, Romagnani P, Bellini F, Mannelli M, Misciglia N, Mavilia C, Vellei U, Villari D and Serio M: Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. J Am Soc Nephrol 10: 245-255, 1999. (Pubitemid 29068063)
5. Otani A, Takagi H, Oh H, Koyama S and Honda Y: Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. Diabetes 50: 867-875, 2001. (Pubitemid 32242646)
6. Fujita M, Hayashi I, Yamashina S, Itoman M and Majima M: Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 294: 441-447, 2002. (Pubitemid 34694114)
7. Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S and Kikkawa F: Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin Cancer Res 11: 2686-2694, 2005. (Pubitemid 40569470)
8. Yasumatsu R, Nakashima T, Masuda M, Ito A, Kuratomi Y, Nakagawa T and Komune S: Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells. J Cancer Res Clin Oncol 130: 567-573, 2004. (Pubitemid 39371327)
9. Neo JH, Malcontenti-Wilson C, Muralidharan V and Christophi C: Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases. J Gastroenterol Hepatol 22: 577-584, 2007. (Pubitemid 46434989)
10. Ebert MP, Lendeckel U, Westphal S, Dierkes J, Glas J, Folwaczny C, Roessner A, Stolte M, Malfertheiner P and Röcken C: The angiotensin I-converting enzyme gene insertion/deletion polymorphism is linked to early gastric cancer. Cancer Epidemiol Biomarkers Prev 14: 2987-2389, 2005.
11. Röcken C, Lendeckel U, Dierkes J, Westphal S, Carl-McGrath S, Peters B, Krüger S, Malfertheiner P, Roessner A and Ebert MP: The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 11: 2526-2530, 2005. (Pubitemid 40569449)
12. Röcken C, Röhl FW, Diebler E, Lendeckel U, Pross M, Carl-McGrath S and Ebert MP: The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer. Cancer Epidemiol Biomarkers Prev 16: 1206-1212, 2007. (Pubitemid 46984960)
13. Wasa J, Sugiura H, Kozawa E, Kohyama K, Yamada K and Taguchi O: The tumor suppressive effect of angiotensin II type 1 receptor antagonist in a murine osteosarcoma model. Anticancer Res 31: 123-127, 2011.
14. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R and Walther T: Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100: 8258-8263, 2003. (Pubitemid 36842532)
15. Ni L, Feng Y, Wan H, Ma Q, Fan L, Qian Y, Li Q, Xiang Y and Gao B: Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways. Oncol Rep 27: 783-790, 2012.
16. Gallagher PE and Tallant EA: Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 25: 2045-2052, 2004. (Pubitemid 39534840)
17. Feng Y, Ni L, Wan H, Fan L, Fei X, Ma Q, Gao B, Xiang Y, Che J and Li Q: Overexpression of ACE2 produces antitumor effects via inhibition of angiogenesis and tumor cell invasion in vivo and in vitro. Oncol Rep 26: 1157-1164, 2011.
18. Qian YR, Guo Y, Wan HY, Fan L, Feng Y, Ni L, Xiang Y and Li QY: Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition. Oncol Rep 29: 2408-2414, 2013.
19. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1956.
20. Wu W and Zhao S: Metabolic changes in cancer: beyond the Warburg effect. Acta Biochim Biophys Sin (Shanghai) 45: 18-26, 2013.
21. Cifuentes M, García MA, Arrabal PM, Martínez F, Yañez MJ, Jara N, Weil B, Domínguez D, Medina RA and Nualart F: Insulin regulates GLUT1-mediated glucose transport in MG-63 human osteosarcoma cells. J Cell Physiol 226: 1425-1432, 2011.
22. Costelloe CM, Macapinlac HA, Madewell JE, Fitzgerald NE, Mawlawi OR, Rohren EM, Raymond AK, Lewis VO, Anderson PM, Bassett RL Jr, Harrell RK and Marom EM: 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med 50: 340-347, 2009.
23. Franzius C, Bielack S, Flege S, Sciuk J, Jürgens H and Schober O: Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med 43: 1012-1017, 2002. (Pubitemid 34847923)
24. Liu C, Lv XH, Li HX, Cao X, Zhang F, Wang L, Yu M and Yang JK: Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes. Acta Diabetol 49: 291-299, 2012.
25. Giani JF, Mayer MA, Muñoz MC, Silberman EA, Höcht C, Taira CA, Gironacci MM, Turyn D and Dominici FP: Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am J Physiol Endocrinol Metab 296: E262-E271, 2009.
26. Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL and Robertson JW: Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 352: 179-184, 1998. (Pubitemid 28327802)
27. Friis S, Sørensen HT, Mellemkjaer L, McLaughlin JK, Nielsen GL, Blot WJ and Olsen JH: Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark. Cancer 92: 2462-2470, 2001. (Pubitemid 33029093)
28. Young D, Waitches G, Birchmeier C, Fasano O and Wigler M: Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 45: 711-719, 1986. (Pubitemid 16063134)
29. Alenina N, Xu P, Rentzsch B, Patkin EL and Bader M: Genetically altered animal models for Mas and angiotensin-(1-7). Exp Physiol 93: 528-537, 2008. (Pubitemid 351595044)
30. Hönicke A-S, Ender SA and Radons J: Combined administration of EGCG and IL-1 receptor antagonist efficiently downregulates IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma cells. Int J Oncol 41: 753-758, 2012.
31. Chilukotia RK, Mostertz J, Bukowska A, Aderkast C, Felix SB, Busch M, Völker U, Goette A, Wolke C, Homuth G and Lendeckel U: Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo. Int J Cardiol 168: 2100-2108, 2013.